Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy ...

Dario Amodei, CEO of Anthropic, says more democracy is the best response to AI. He doesn’t sound too confident.

ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") , a publicly listed biotechnology company working on novel ...

Performance Health Partners, A Sentact Company, today has been ranked the top provider of healthcare safety, risk, and compliance software in the 2026 Best in KLAS: Software & Services Report. This ...

A new Canadian study has found that people living with dementia (PLWD) are often excluded from research due to assumptions of ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

Ultragenyx Pharmaceutical (RARE) has put UX111, its gene therapy for Sanfilippo syndrome type A, back in the spotlight after releasing new long-term clinical data and resubmitting its Biologics ...

It uses a system called simplified molecular-input line-entry system (SMILES). This translates chemical 3D structures into ...